{"id":3961,"date":"2016-04-26T11:21:00","date_gmt":"2016-04-26T11:21:00","guid":{"rendered":"https:\/\/www.adacyte.com\/?post_type=scientific-corner&p=3961"},"modified":"2021-07-12T07:56:07","modified_gmt":"2021-07-12T07:56:07","slug":"adacolumn-granulocyte-apheresis-for-alcoholic-hepatitis-preliminary-study","status":"publish","type":"scientific-corner","link":"https:\/\/www.adacyte.com\/de\/professional\/scientific-corner\/adacolumn-granulocyte-apheresis-for-alcoholic-hepatitis-preliminary-study\/","title":{"rendered":"Adacolumn Granulocyte-Apheresis for Alcoholic Hepatitis: Preliminary Study"},"content":{"rendered":"
\n

V Morabito<\/a> 1<\/a><\/sup>, S Novelli<\/a> 2<\/a><\/sup>, L Poli<\/a> 3<\/a><\/sup>, G Ferretti<\/a> 4<\/a><\/sup>, F Ruberto<\/a> 5<\/a><\/sup>, F Pugliese<\/a> 5<\/a><\/sup>, R Pretagostini<\/a> 3<\/a><\/sup>, P B Berloco<\/a> 3<\/a><\/sup>, M Rossi<\/a> 3<\/a><\/sup> , Transplant Proc. 2016 Mar;48(2):352-8.<\/p>\n<\/div>\n\n

\n

The Adacolumn apheresis was safe and was able to determine an improvement of clinical status of patients with reduction of inflammatory markers. More patients are needed to validate these results.<\/p>\n<\/div>\n\n

\n

https:\/\/pubmed.ncbi.nlm.nih.gov\/27109954\/<\/a><\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

V Morabito 1, S Novelli 2, L Poli 3, G Ferretti 4, F Ruberto 5, F Pugliese 5, R Pretagostini 3, P B Berloco 3, M Rossi 3 , Transplant Proc. 2016 Mar;48(2):352-8. The Adacolumn apheresis was safe and was able to determine an improvement of clinical status of patients with reduction of inflammatory markers. More patients are needed to validate these results. https:\/\/pubmed.ncbi.nlm.nih.gov\/27109954\/<\/p>\n","protected":false},"template":"","scientific_tags":[101,147,316],"class_list":["post-3961","scientific-corner","type-scientific-corner","status-publish","hentry","scientific_tags-alcoholic-hepatitis","scientific_tags-clinical-remission","scientific_tags-nephrology"],"acf":{"sc_authors":""},"yoast_head":"\nAdacolumn Granulocyte-Apheresis for Alcoholic Hepatitis: Preliminary Study - Adacyte<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/adacolumn-granulocyte-apheresis-for-alcoholic-hepatitis-preliminary-study\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Adacolumn Granulocyte-Apheresis for Alcoholic Hepatitis: Preliminary Study - Adacyte\" \/>\n<meta property=\"og:description\" content=\"V Morabito 1, S Novelli 2, L Poli 3, G Ferretti 4, F Ruberto 5, F Pugliese 5, R Pretagostini 3, P B Berloco 3, M Rossi 3 , Transplant Proc. 2016 Mar;48(2):352-8. The Adacolumn apheresis was safe and was able to determine an improvement of clinical status of patients with reduction of inflammatory markers. More patients are needed to validate these results. https:\/\/pubmed.ncbi.nlm.nih.gov\/27109954\/\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/adacolumn-granulocyte-apheresis-for-alcoholic-hepatitis-preliminary-study\/\" \/>\n<meta property=\"og:site_name\" content=\"Adacyte\" \/>\n<meta property=\"article:modified_time\" content=\"2021-07-12T07:56:07+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data1\" content=\"1\u00a0Minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/adacolumn-granulocyte-apheresis-for-alcoholic-hepatitis-preliminary-study\/\",\"url\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/adacolumn-granulocyte-apheresis-for-alcoholic-hepatitis-preliminary-study\/\",\"name\":\"Adacolumn Granulocyte-Apheresis for Alcoholic Hepatitis: Preliminary Study - Adacyte\",\"isPartOf\":{\"@id\":\"https:\/\/www.adacyte.com\/#website\"},\"datePublished\":\"2016-04-26T11:21:00+00:00\",\"dateModified\":\"2021-07-12T07:56:07+00:00\",\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/adacolumn-granulocyte-apheresis-for-alcoholic-hepatitis-preliminary-study\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.adacyte.com\/#website\",\"url\":\"https:\/\/www.adacyte.com\/\",\"name\":\"Adacyte\",\"description\":\"Adacyte Therapeutics\",\"publisher\":{\"@id\":\"https:\/\/www.adacyte.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.adacyte.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"de\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.adacyte.com\/#organization\",\"name\":\"Adacyte\",\"url\":\"https:\/\/www.adacyte.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"contentUrl\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"width\":165,\"height\":46,\"caption\":\"Adacyte\"},\"image\":{\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Adacolumn Granulocyte-Apheresis for Alcoholic Hepatitis: Preliminary Study - Adacyte","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/adacolumn-granulocyte-apheresis-for-alcoholic-hepatitis-preliminary-study\/","og_locale":"de_DE","og_type":"article","og_title":"Adacolumn Granulocyte-Apheresis for Alcoholic Hepatitis: Preliminary Study - Adacyte","og_description":"V Morabito 1, S Novelli 2, L Poli 3, G Ferretti 4, F Ruberto 5, F Pugliese 5, R Pretagostini 3, P B Berloco 3, M Rossi 3 , Transplant Proc. 2016 Mar;48(2):352-8. The Adacolumn apheresis was safe and was able to determine an improvement of clinical status of patients with reduction of inflammatory markers. More patients are needed to validate these results. https:\/\/pubmed.ncbi.nlm.nih.gov\/27109954\/","og_url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/adacolumn-granulocyte-apheresis-for-alcoholic-hepatitis-preliminary-study\/","og_site_name":"Adacyte","article_modified_time":"2021-07-12T07:56:07+00:00","twitter_card":"summary_large_image","twitter_misc":{"Gesch\u00e4tzte Lesezeit":"1\u00a0Minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/adacolumn-granulocyte-apheresis-for-alcoholic-hepatitis-preliminary-study\/","url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/adacolumn-granulocyte-apheresis-for-alcoholic-hepatitis-preliminary-study\/","name":"Adacolumn Granulocyte-Apheresis for Alcoholic Hepatitis: Preliminary Study - Adacyte","isPartOf":{"@id":"https:\/\/www.adacyte.com\/#website"},"datePublished":"2016-04-26T11:21:00+00:00","dateModified":"2021-07-12T07:56:07+00:00","inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.adacyte.com\/professional\/scientific-corner\/adacolumn-granulocyte-apheresis-for-alcoholic-hepatitis-preliminary-study\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.adacyte.com\/#website","url":"https:\/\/www.adacyte.com\/","name":"Adacyte","description":"Adacyte Therapeutics","publisher":{"@id":"https:\/\/www.adacyte.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.adacyte.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"de"},{"@type":"Organization","@id":"https:\/\/www.adacyte.com\/#organization","name":"Adacyte","url":"https:\/\/www.adacyte.com\/","logo":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","contentUrl":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","width":165,"height":46,"caption":"Adacyte"},"image":{"@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.adacyte.com\/de\/wp-json\/wp\/v2\/scientific-corner\/3961","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.adacyte.com\/de\/wp-json\/wp\/v2\/scientific-corner"}],"about":[{"href":"https:\/\/www.adacyte.com\/de\/wp-json\/wp\/v2\/types\/scientific-corner"}],"wp:attachment":[{"href":"https:\/\/www.adacyte.com\/de\/wp-json\/wp\/v2\/media?parent=3961"}],"wp:term":[{"taxonomy":"scientific_tags","embeddable":true,"href":"https:\/\/www.adacyte.com\/de\/wp-json\/wp\/v2\/scientific_tags?post=3961"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}